Login / Signup

Risk Factors for Thyroid Dysfunction in Pregnancy: An Individual Participant Data Meta-Analysis.

Joris A J OsingaYindi LiuTuija MännistöMarina VafeiadiFang-Biao TaoBijay VaidyaTanja G M VrijkotteLorena MossoJudit BassolsAbel López-BermejoLaura BoucaiAshraf AminorroayaUlla Feldt-RasmussenAya HisadaJun YoshinagaMaarten A C BroerenSachiko ItohReiko KishiGhalia AshoorLiangmiao ChenFlora VeltriXuemian LuPeter N TaylorSuzanne J BrownLeda ChatziPolina V PopovaElena N GrinevaFarkhanda GhafoorAmna PirzadaMaryam KianpourEmily OkenEila SuvantoAndrew HattersleyMarisa RebagliatoIsolina Riaño-GalánAmaia IrizarMartine VrijheidJuana Maria Delgado-SaboritAna Fernández-SomoanoLoreto Santa-MarinaKristien BoelaertGabriela BrentaRima Dhillon-SmithChrysoula DosiouJennifer L EatonHaixia GuanSun Y LeeSpyridoula MarakaLilah F Morris-WisemanCaroline T NguyenZhongyan ShanMònica GuxensVictor J M PopJohn P WalshKypros H NicolaidesMary E D'AltonW Edward VisserDavid M CartyChristian DellesScott McGill NelsonErik K AlexanderLayal ChakerGlenn E PalomakiRobin P PeetersSofie BliddalKun HuangKris G PoppeElizabeth N PearceArash DerakhshanTim I M Korevaar
Published in: Thyroid : official journal of the American Thyroid Association (2024)
Background: International guidelines recommend targeted screening to identify gestational thyroid dysfunction. However, currently used risk factors have questionable discriminative ability. We quantified the risk for thyroid function test abnormalities for a subset of risk factors currently used in international guidelines. Methods: We included prospective cohort studies with data on gestational maternal thyroid function and potential risk factors (maternal age, body mass index [BMI], parity, smoking status, pregnancy through in vitro fertilization, twin pregnancy, gestational age, maternal education, and thyroid peroxidase antibody [TPOAb] or thyroglobulin antibody [TgAb] positivity). Exclusion criteria were pre-existing thyroid disease and use of thyroid interfering medication. We analyzed individual participant data using mixed-effects regression models. Primary outcomes were overt and subclinical hypothyroidism and a treatment indication (defined as overt hypothyroidism, subclinical hypothyroidism with thyrotropin >10 mU/L, or subclinical hypothyroidism with TPOAb positivity). Results: The study population comprised 65,559 participants in 25 cohorts. The screening rate in cohorts using risk factors currently recommended (age >30 years, parity ≥2, BMI ≥40) was 58%, with a detection rate for overt and subclinical hypothyroidism of 59%. The absolute risk for overt or subclinical hypothyroidism varied <2% over the full range of age and BMI and for any parity. Receiver operating characteristic curves, fitted using maternal age, BMI, smoking status, parity, and gestational age at blood sampling as explanatory variables, yielded areas under the curve ranging from 0.58 to 0.63 for the primary outcomes. TPOAbs/TgAbs positivity was associated with overt hypothyroidism (approximate risk for antibody negativity 0.1%, isolated TgAb positivity 2.4%, isolated TPOAb positivity 3.8%, combined antibody positivity 7.0%; p  < 0.001), subclinical hypothyroidism (risk for antibody negativity 2.2%, isolated TgAb positivity 8.1%, isolated TPOAb positivity 14.2%, combined antibody positivity 20.0%; p  < 0.001) and a treatment indication (risk for antibody negativity 0.2%, isolated TgAb positivity 2.2%, isolated TPOAb positivity 3.0%, and combined antibody positivity 5.1%; p  < 0.001). Twin pregnancy was associated with a higher risk of overt hyperthyroidism (5.6% vs. 0.7%; p  < 0.001). Conclusions: The risk factors assessed in this study had poor predictive ability for detecting thyroid function test abnormalities, questioning their clinical usability for targeted screening. As expected, TPOAb positivity (used as a benchmark) was a relevant risk factor for (subclinical) hypothyroidism. These results provide insights into different risk factors for gestational thyroid dysfunction.
Keyphrases